CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- 4 Grant or award Director acquired 1,626 shares (grant or award)
- 4 Grant or award Director acquired 1,626 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,626 shares (grant or award)
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Commercial Officer sold 5,250 shares at $54.48 ($286,020)
- 4 Grant or award Chief Human Resources Officer acquired 6,800 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Open-market sale CEO and Director sold 3,278 shares at $60.04 ($196,811)
- 8-K Event Results of operations
- 4 Open-market sale CEO and Director sold 28,219 shares at an average $60.06 ($1,694,713)
- 4 Open-market sale CEO and Director sold 3,293 shares at $60.04 ($197,712)
- 4 Open-market sale CEO and Director sold 7,124 shares at an average $60.08 ($428,014)
- SC 13G Stake Amended Statement of Ownership
Page 23 of 55 · 1,098 filings